What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review

Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jing Sun, Hanchao Cheng, Muhammad Radzi Abu Hassan, Huan-Keat Chan, Jean-Michel Piedagnel
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/e93aafdef84543398d107e7822dd675c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e93aafdef84543398d107e7822dd675c
record_format	dspace
spelling	oai:doaj.org-article:e93aafdef84543398d107e7822dd675c2021-12-02T05:04:02ZWhat China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review2666-606510.1016/j.lanwpc.2021.100261https://doaj.org/article/e93aafdef84543398d107e7822dd675c2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S266660652100170Xhttps://doaj.org/toc/2666-6065Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of increasing the DAA treatment rate of hepatitis C in Malaysia and China, and how the two countries have been navigating the hepatitis C agenda.Findings: Malaysia adopted a series of successful strategies to scale up the diagnosis of hepatitis C and DAA treatment, which have valuable implications for China.Interpretation: The potential game-changing strategies for China to adapt from Malaysian experiences range from the stepping-up of political commitment and leadership, enhanced market competition, simplified and decentralized treatment at the strengthened primary care level, integrated healthcare services, coordinated government initiatives, to multi-organizational participation and civil society's active role in raising public awareness, and training of non-specialist physicians. Embarking on scale-up of hepatitis C treatment marks another contribution of China to improve the health of not only the Chinese citizens but also mankind, which is an important component for building healthy Chinese and global communities.Funding: No funding supported this study.Jing SunHanchao ChengMuhammad Radzi Abu HassanHuan-Keat ChanJean-Michel PiedagnelElsevierarticlePublic aspects of medicineRA1-1270ENThe Lancet Regional Health. Western Pacific, Vol 16, Iss , Pp 100261- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Public aspects of medicine RA1-1270
spellingShingle	Public aspects of medicine RA1-1270 Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
description	Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of increasing the DAA treatment rate of hepatitis C in Malaysia and China, and how the two countries have been navigating the hepatitis C agenda.Findings: Malaysia adopted a series of successful strategies to scale up the diagnosis of hepatitis C and DAA treatment, which have valuable implications for China.Interpretation: The potential game-changing strategies for China to adapt from Malaysian experiences range from the stepping-up of political commitment and leadership, enhanced market competition, simplified and decentralized treatment at the strengthened primary care level, integrated healthcare services, coordinated government initiatives, to multi-organizational participation and civil society's active role in raising public awareness, and training of non-specialist physicians. Embarking on scale-up of hepatitis C treatment marks another contribution of China to improve the health of not only the Chinese citizens but also mankind, which is an important component for building healthy Chinese and global communities.Funding: No funding supported this study.
format	article
author	Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel
author_facet	Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel
author_sort	Jing Sun
title	What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
title_short	What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
title_full	What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
title_fullStr	What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
title_full_unstemmed	What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
title_sort	what china can learn from malaysia to achieve the goal of “eliminate hepatitis c as a public health threat” by 2030 – a narrative review
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/e93aafdef84543398d107e7822dd675c
work_keys_str_mv	AT jingsun whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT hanchaocheng whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT muhammadradziabuhassan whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT huankeatchan whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT jeanmichelpiedagnel whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview
_version_	1718400685592018944

What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review

Ejemplares similares